Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, MI.
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI; Department of Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, MI; Department of Urology, Michigan Medicine, University of Michigan, Ann Arbor, MI.
Am J Kidney Dis. 2020 Sep;76(3):340-349.e1. doi: 10.1053/j.ajkd.2020.01.008. Epub 2020 May 5.
RATIONALE & OBJECTIVE: Native Hawaiians and Pacific Islanders (NHPI) have been reported to have the highest rates of incident end-stage kidney disease (ESKD) compared with other races in the United States. However, these estimates were likely biased upward due to the exclusion of nearly half the NHPI population that reports multiple races in the US Census. We sought to estimate the incidence rate of ESKD, including individuals reporting multiple races, and describe the clinical characteristics of incident cases by race and location.
Health care database study.
SETTING & PARTICIPANTS: US residents of the 50 states and 3 Pacific Island territories of the United States whose ESKD was recorded in the US Renal Data System (USRDS) between 2007 and 2016, as well as US residents recorded in the 2010 Census.
Age, sex, race, body mass index, primary cause of ESKD, comorbid conditions, estimated glomerular filtration rate, pre-ESKD nephrology care, and hemoglobin A level among ESKD cases.
Initiation of maintenance dialysis or transplantation for kidney failure.
Crude ESKD incidence rates (cases/person-years) were estimated using both single- and multiple-race reporting.
Even after inclusion of multirace reporting, NHPI had the highest ESKD incidence rate among all races in the 50 states (921 [95% CI, 904-938] per million population per year)-2.7 times greater than whites and 1.2 times greater than blacks. Also using multirace reporting, the NHPI ESKD incident rate in the US territories was 941 (95% CI, 895-987) per million population per year. Diabetes was listed as the primary cause of ESKD most frequently for NHPI and American Indians/Alaska Natives. Sensitivity analysis adjusting for age and sex demonstrated greater differences in rates between NHPI and other races. Diabetes was the primary cause of ESKD in 60% of incident NHPI cases. Patients with ESKD living in the territories had received less pre-ESKD nephrology care than had patients living in the 50 states.
Different methods of race classification in the USRDS versus the US Census.
NHPI living in the 50 US states and Pacific territories had the highest rates of ESKD incidence compared with other races. Further research and efforts are required to understand the reasons for and define how best to address this racial disparity.
与美国其他种族相比,夏威夷原住民和太平洋岛民(NHPI)的终末期肾病(ESKD)发病率最高。然而,这些估计值可能因美国人口普查排除了近一半报告多种族的 NHPI 人群而偏高。我们旨在估计包括报告多种族的个体在内的 ESKD 发病率,并按种族和地点描述发病病例的临床特征。
医疗保健数据库研究。
美国 50 个州和 3 个太平洋岛屿领地的居民,如果他们的 ESKD 在美国肾脏数据系统(USRDS)中记录在案,则将其纳入研究范围,从 2007 年至 2016 年;以及在美国 2010 年人口普查中记录的美国居民。
年龄、性别、种族、体重指数、ESKD 的主要病因、合并症、估算肾小球滤过率、ESKD 前的肾病学护理以及血红蛋白 A 水平。
开始维持性透析或肾脏衰竭移植。
使用单一和多种种族报告来估算 ESKD 的粗发病率(病例/人年)。
即使包括多种族报告,NHPI 的发病率在 50 个州的所有种族中仍是最高的(每百万人口每年 921 [95%CI,904-938]例)-是白人的 2.7 倍,是黑人的 1.2 倍。同样使用多种族报告,美国领地的 NHPI ESKD 发病率为每百万人口每年 941 例(95%CI,895-987)。糖尿病是 NHPI 和美洲印第安人/阿拉斯加原住民中最常被列为 ESKD 主要病因的疾病。敏感性分析调整年龄和性别后,NHPI 与其他种族之间的发病率差异更大。60%的 NHPI 发病病例的 ESKD 主要病因是糖尿病。居住在领地的 ESKD 患者接受的 ESKD 前肾病学护理少于居住在 50 个州的患者。
美国肾脏数据系统与美国人口普查的种族分类方法不同。
与其他种族相比,居住在美国 50 个州和太平洋领地的夏威夷原住民和太平洋岛民的 ESKD 发病率最高。需要进一步研究和努力,以了解造成这种种族差异的原因,并确定如何最好地解决这一问题。